Chemoinformaics analysis of 1,3,5,8-Tetrahydroxy-2-methyl anthraquinone
| Molecular Weight | 316.265 | nRot | 1 |
| Heavy Atom Molecular Weight | 304.169 | nRig | 18 |
| Exact Molecular Weight | 316.058 | nRing | 3 |
| Solubility: LogS | -3.736 | nHRing | 0 |
| Solubility: LogP | 3.106 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 12 |
| nHA | 7 | APOL | 40.3355 |
| nHD | 4 | BPOL | 15.5105 |
| QED | 0.592 |
| Synth | 2.929 |
| Natural Product Likeliness | 2.143 |
| NR-PPAR-gamma | 0.75 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.053 |
| Pgp-sub | 0.001 |
| HIA | 0.256 |
| CACO-2 | -5.248 |
| MDCK | 0.0000123 |
| BBB | 0.003 |
| PPB | 0.979143 |
| VDSS | 0.383 |
| FU | 0.0465192 |
| CYP1A2-inh | 0.917 |
| CYP1A2-sub | 0.811 |
| CYP2c19-inh | 0.077 |
| CYP2c19-sub | 0.062 |
| CYP2c9-inh | 0.673 |
| CYP2c9-sub | 0.354 |
| CYP2d6-inh | 0.338 |
| CYP2d6-sub | 0.177 |
| CYP3a4-inh | 0.246 |
| CYP3a4-sub | 0.093 |
| CL | 8.044 |
| T12 | 0.726 |
| hERG | 0.007 |
| Ames | 0.798 |
| ROA | 0.075 |
| SkinSen | 0.915 |
| Carcinogencity | 0.588 |
| EI | 0.882 |
| Respiratory | 0.159 |
| NR-Aromatase | 0.581 |
| Antiviral | Yes |
| Prediction | 0.845168 |